Loading provider…
Loading provider…
Neurology Physician in San Diego, CA
NPI: 1336197730Primary Employer
UCSD Medical Group
health.ucsd.edu
HQ Phone
Get MD Douglas's Phone Numberphone_androidMobile
Get MD Douglas's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1988 - 2026
MD State Medical License
1985 - 1988

American Board of Psychiatry and Neurology
Neurology
Johns Hopkins University
Residency • Neurology
1984 - 1987
Boston University Medical Center
Internship • Internal Medicine
1983 - 1984
University of the Witwatersrand
Medical School
Until 1979
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 77 | 95 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 42 | 42 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 15 | 15 |
α-Synuclein Seed Amplification in CSF and Brain from Patients with Different Brain Distributions of Pathological α-Synuclein in the Context of Co-Pathology and Non-LBD Diagnoses.
Authors: Jeffrey Kaye, David Coughlin
Publication Date: 2022-10
Psychotropic medication usage in sporadic versus genetic behavioral-variant frontotemporal dementia.
Authors: Sami Barmada, Gabriel Leger, Andrea Bozoki, Neill Graff-Radford, Adam Boxer, Daniel Geschwind, Mario Mendez, David Irwin, Erik Roberson, Lawrence Honig, Irene Litvan, Bradford Dickerson, Joseph Masdeu, Brian Appleby, Myriam Spears, Ian Grant, Nupur Ghoshal, Peter Pressman
Journal: Alzheimers Dement
Publication Date: 2024-12-23
A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease.
Authors: Karen Bell, Paul Aisen
Publication Date: 2011-07-27
Lead Sponsor: Eli Lilly and Company
Collaborators: Alzheimer's Therapeutic Research Institute
Intervention / Treatment: DRUG: Placebo, DRUG: Solanezumab
Lead Sponsor: Ken Marek, MD
Collaborators: Institute for Neurodegenerative Disorders
Intervention / Treatment: DRUG: DaTscan
Lead Sponsor: National Institute on Aging (NIA)
Collaborators: Alzheimer's Disease Cooperative Study (ADCS)
Intervention / Treatment: DRUG: Placebo capsules, DRUG: Placebo wafers, DRUG: Vitamin E, Vitamin C, and Alpha-lipoic Acid, DRUG: Coenzyme Q